# Reviewer Perspective Analysis

## Skeptical Reviewer Summary

If I were reviewing this manuscript cold, my judgment would be:

“This is a credible exploratory paper with real biological signal, but it still feels one step short of being fully satisfying. The authors have addressed some important concerns, yet several obvious follow-up analyses remain missing.”

## What would make me lean toward acceptance

- The three-cluster solution is clinically interpretable.
- The inflammatory-renal phenotype persists after age removal.
- The authors are appropriately cautious and no longer oversell the work.
- The robustness analyses materially improve transparency.
- The dataset is large and the problem is relevant.

## What would make me hesitate

- The analytic cohort is strongly selected by the `n_exames >= 6` rule.
- Repeated encounters materially affect prevalence.
- Age still contributes strongly to the geometry.
- The hepatic phenotype remains somewhat underdeveloped.
- The paper still lacks one or two obvious “finishing analyses.”

## Likely High-Level Reviewer Comments

### Reviewer 1: Clinical interpretation oriented

“The phenotypes are plausible, particularly the inflammatory-renal pattern, but the paper needs stronger biological interpretation of the hepatic and basal clusters. The sex differences are interesting and currently underexplored. The authors should also clarify what these phenotypes could mean for future clinical-laboratory intelligence.”

### Reviewer 2: Methods and robustness oriented

“The authors have improved the work by showing no-age sensitivity and first-encounter prevalence shifts. However, the clustering remains potentially influenced by cohort selection, age architecture, and preprocessing. Adult-only/pediatric-aware sensitivity and clearer missingness reporting would strengthen confidence.”

### Reviewer 3: Translational relevance oriented

“The study is hypothesis-generating and may be useful for future informatics pipelines, but currently lacks outcome linkage and therefore does not yet establish clinical utility. The claims should remain descriptive.”

## What I Would Ask for in Revision

## Most likely major revision requests

- provide clearer cluster characterization in original units
- report missingness more transparently
- strengthen discussion of sex and age effects
- clarify what portion of the signal may reflect testing-density selection

## Possible but not guaranteed requests

- adult-only / pediatric-aware sensitivity
- outcome association if data are available
- alternate clustering or preprocessing sensitivity

## What I Probably Would Not Demand

- a new machine-learning method
- a complete redesign of the clustering pipeline
- fully prospective validation

The manuscript’s problem is not that it lacks technical sophistication. Its problem is that it still lacks one last layer of scientific completion.

## Reviewer Confidence by Topic

### Confidence in descriptive signal

**Moderately high**

The signal looks real enough to discuss.

### Confidence in phenotype stability

**Moderate**

Improved, but still not strong.

### Confidence in biological specificity

**Moderate for inflammatory-renal; lower for hepatic; modest for basal**

### Confidence in generalizability

**Low to moderate**

### Confidence in translational utility

**Low at present**

## Publication Recommendation If I Were Reviewing

### For a realistic exploratory journal

**Major revision or minor-to-moderate revision depending on journal expectations**

### For a stronger journal expecting deeper scientific completeness

**Likely rejection or major revision**

## Final Reviewer Take

This is not a weak manuscript. It is a manuscript with a good core result that still needs a few targeted additions to feel fully persuasive. If the authors stop now, the paper remains publishable in the right venue. If they add a handful of smart quantitative and interpretive refinements, the work will feel substantially more mature.
